View:
Download DOC
Download PDF
Download XLS
Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 6, 2011

ICU Medical, Inc.
(Exact name of registrant as specified in its charter)

DELAWARE   0-19974   33-0022692
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (IRS Employer
Identification No.)

  951 Calle Amanecer, San Clemente, California   92673  
  (Address of principal executive offices)   (Zip Code)  

(949) 366-2183
Registrant's telephone number, including area code


N/A
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  [    ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [    ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [    ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [    ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

See attached press release.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits

99.1 Press release, dated July 6, 2011 announcing ICU Medical, Inc.’s second quarter 2011 earnings release conference call.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ICU Medical, Inc.

Date: July 6, 2011

   /s/ SCOTT E. LAMB
Scott E. Lamb
Secretary, Treasurer and Chief Financial Officer


EXHIBIT INDEX

Exhibit Description

99.1 Press release dated July 6, 2011.
ICU Medical, Inc. Announces Time of Second Quarter 2011 Earnings Call

EXHIBIT 99.1

ICU Medical, Inc. Announces Time of Second Quarter 2011 Earnings Call

SAN CLEMENTE, Calif., July 6, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), today announced the time of its second quarter 2011 earnings release conference call.

ICU Medical, Inc. develops, manufactures and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitor the hemodynamic status of critical care patients. The company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needleless I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California.

The Company will release its second quarter 2011 results at approximately 4:00 p.m. EDT (1:00 p.m. PDT) and will be conducting a conference call concerning those results at 4:30 p.m. EDT (1:30 p.m. PDT) on Monday, July 18, 2011. The call can be accessed at 800-936-9761, international 408-774-4587, conference ID 75379111 or by replay at 800-642-1687, international 706-645-9291, conference ID 75379111. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay. 

CONTACT: ICU Medical, Inc.
         Scott E. Lamb, Chief Financial Officer
         (949) 366-2183

         ICR, Inc.
         John F. Mills, Senior Managing Director
         (310) 954-1105